Fluoride: Page 56

Recalls, lawsuit prompt ongoing propofol shortage
By Rob Goszkowski
For dental practitioners who regularly administer propofol, this past year has been a challenging one. A series of factors -- including recalls, shutdowns, and a multimillion dollar lawsuit -- rendered one of the most widely used anesthetics in medicine virtually unobtainable.
November 4, 2010
2010 11 05 12 28 12 334 Dropper Vial 70
Bisphosphonates aid dental health in menopausal women
By Reuters Health
NEW YORK (Reuters Health) - In postmenopausal women with low bone mineral density, long-term bisphosphonate therapy appears to benefit the periodontium, researchers report in a September 10 online paper in Menopause.
October 20, 2010
2009 08 27 12 02 18 416 Young Senior Woman 70
FDA approves Botox to treat chronic migraine
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Botox injections (onabotulinumtoxinA) to prevent chronic migraine headaches in adult patients, the agency announced.
October 17, 2010
Osteoporosis drug rebuilds bone in patients with perio disease
By DrBicuspid.com staff writers
A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in patients with periodontal disease, a new study in the New England Journal of Medicine suggests.
October 17, 2010
2010 10 18 10 55 26 11 Head Neck Xray 70
Novartis wins 2nd ONJ/bisphosphonate trial
By DrBicuspid.com staff writers
A New Jersey jury ruled October 6 that Novartis provided adequate warnings about the risk of its bisphosphonate drugs, rejecting a lawsuit by a woman who claimed the drugs contributed to her development of osteonecrosis of the jaw (ONJ), according to a story by Bloomberg.
October 6, 2010
Preop prophylactic antibiotics -- yes or no?
By Rosemary Frei, MSc
Despite a recent meta-analysis indicating that giving patients antibiotics prior to implant surgery can prevent implant failures, some experts still question whether antibiotic prophylaxis is necessary in every case.
September 2, 2010
2008 08 18 14 48 26 421 Bacteria 70
Did Univ. of Colo. dentists give patients too much midazolam?
By DrBicuspid.com staff writers
Dentists at the University of Colorado Denver School of Dental Medicine mistakenly injected as many as eight patients with potentially lethal doses of midazolam after the drug was erroneously added to the school's stock in 2008, according to a story by the Denver Post.
August 30, 2010
Can cancer patients benefit from phase I drug trials?
By Reuters Health
NEW YORK (Reuters Health), Aug 16 - Patients with advanced head and neck cancer survived just as well on experimental drugs in phase I trials as they did on FDA-approved standard therapies, a new report says.
August 15, 2010
2009 07 13 09 44 04 276 Bottle Pills 70
U.S. Senate committee passes pay-for-delay limit
By DrBicuspid.com staff writers
A U.S. Senate committee on July 29 approved a provision meant to inhibit branded drug companies from delaying the introduction of generic versions of their drugs.
July 29, 2010
FTC campaigns against 'pay-for-delay'
By DrBicuspid.com staff writers
The U.S. Federal Trade Commission (FTC) is trying to stop drug companies from paying each other not to introduce competing products, according to commission Chairman Jon Leibowitz.
July 28, 2010
Agencies plan painkiller restrictions
By DrBicuspid.com staff writers
Washington state is preparing regulations intended to curb the overuse of prescription painkillers, according to an article in the New York Times.
July 28, 2010
Sanofi-Aventis, Novalar eye European market for OraVerse
By DrBicuspid.com staff writers
Sanofi-Aventis and Novalar Pharmaceuticals announced that the Marketing Authorization Application for OraVerse has been accepted for review by the regulatory agencies of the U.K., Germany, Italy, France, and Spain.
July 22, 2010
Previous Page
Page 56 of 62
Next Page